FLNC截短变异相关心肌病的表型表达、自然病史与风险分层
BACKGROUND: Filamin C truncating variants (FLNCtv) cause a form of arrhythmogenic cardiomyopathy: the mode of presentation, natural history, and risk stratification of FLNCtv remain incompletely explored.…
要点
- FLNCtv心肌病表型异质,约半数表现为扩张型心肌病。
- 随访期间27%发生心脏性猝死/重大室性心律失常。
- 左室射血分数与泵衰竭风险相关,但与心律失常风险无关。
核心结论
- FLNCtv相关心肌病表型异质,危及生命的心律失常风险高,且该风险与左室功能不全的严重程度无关。
主要发现
- 64%携带者左室射血分数<50%,34%右室面积变化分数<35%。
- 中位随访61个月,22%发生全因死亡/心脏移植/左室辅助装置,15%发生非心律失常性死亡/移植/左室辅助装置,27%发生心脏性猝死/重大室性心律失常。
- FLNCtv携带者的心脏性猝死/重大室性心律失常发生率与LMNA及DSP携带者无显著差异。
- 在FLNCtv携带者中,左室射血分数与全因死亡/移植/左室辅助装置及非心律失常性死亡/移植/左室辅助装置风险相关。
临床怎么用
- 对FLNCtv携带者应重视心律失常风险评估,即使左室收缩功能尚可。
局限性
- 研究纳入的是转诊至三级中心的患者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Filamin C truncating variants (FLNCtv) cause a form of arrhythmogenic cardiomyopathy: the mode of presentation, natural history, and risk stratification of FLNCtv remain incompletely explored. We aimed to develop a risk profile for refractory heart failure and life-threatening arrhythmias in a multicenter cohort of FLNCtv carriers. METHODS: FLNCtv carriers were identified from 10 tertiary care centers for genetic cardiomyopathies. Clinical and outcome data were compiled. Composite outcomes were all-cause mortality/heart transplantation/left ventricle assist device (D/HT/LVAD), nonarrhythmic death/HT/LVAD, and sudden cardiac death/major ventricular arrhythmias. Previously established cohorts of 46 patients with LMNA and 60 with DSP-related arrhythmogenic cardiomyopathies were used for prognostic comparison. RESULTS: Eighty-five patients carrying FLNCtv were included (42±15 years, 53% men, 45% probands). Phenotypes were heterogeneous at presentation: 49% dilated cardiomyopathy, 25% arrhythmogenic left dominant cardiomyopathy, 3% arrhythmogenic right ventricular cardiomyopathy. Left ventricular ejection fraction was <50% in 64% of carriers and 34% had right ventricular fractional area changes (RVFAC=(right ventricular end-diastolic area - right ventricular end-systolic area)/right ventricular end-diastolic area) <35%. During follow-up (median time 61 months), 19 (22%) carriers experienced D/HT/LVAD, 13 (15%) experienced nonarrhythmic death/HT/LVAD, and 23 (27%) experienced sudden cardiac death/major ventricular arrhythmias. The sudden cardiac death/major ventricular arrhythmias incidence of FLNCtv carriers did not significantly differ from LMNA carriers and DSP carriers. In FLNCtv carriers, left ventricular ejection fraction was associated with the risk of D/HT/LVAD and nonarrhythmic death/HT/LVAD. CONCLUSIONS: Among patients referred to tertiary referral centers, FLNCtv arrhythmogenic cardiomyopathy is phenotypically heterogeneous and characterized by a high risk of life-threatening arrhythmias, which does not seem to be associated with the severity of left ventricular dysfunction.
引用
- Gigli M, Stolfo D, Graw SL, et al. Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants. Circulation. 2021. PMID: 34587765. doi:10.1161/CIRCULATIONAHA.121.053521
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。